
Sign up to save your podcasts
Or


In this episode, we explore the complex pharmacological management of mixed mania, a challenging bipolar presentation affecting up to 40% of manic episodes. Why do traditional mood stabilizers like lithium fall short, and which second-generation antipsychotics emerge as first-line treatments for this dual-symptom condition?
Faculty: David Osser, M.D. Host: Richard Seeber, M.D.
By Psychopharmacology Institute4.6
269269 ratings
In this episode, we explore the complex pharmacological management of mixed mania, a challenging bipolar presentation affecting up to 40% of manic episodes. Why do traditional mood stabilizers like lithium fall short, and which second-generation antipsychotics emerge as first-line treatments for this dual-symptom condition?
Faculty: David Osser, M.D. Host: Richard Seeber, M.D.

1,327 Listeners

75 Listeners

499 Listeners

145 Listeners

3,349 Listeners

161 Listeners

1,347 Listeners

732 Listeners

561 Listeners

472 Listeners

461 Listeners

732 Listeners

190 Listeners

152 Listeners

123 Listeners